154 related articles for article (PubMed ID: 23461678)
1. Elevated serum thioredoxin-interacting protein in women with polycystic ovary syndrome is associated with insulin resistance.
Wu J; Wu Y; Zhang X; Li S; Lu D; Li S; Yang G; Liu D
Clin Endocrinol (Oxf); 2014 Apr; 80(4):538-44. PubMed ID: 23461678
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
Song DK; Hong YS; Sung YA; Lee H
PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
[TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
4. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
6. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
7. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte Insulin Resistance in PCOS: Relationship With GLUT-4 Expression and Whole-Body Glucose Disposal and β-Cell Function.
Ezeh U; Chen IY; Chen YH; Azziz R
J Clin Endocrinol Metab; 2020 Jul; 105(7):e2408-20. PubMed ID: 32382742
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and β-cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome.
Mu L; Zhao Y; Lai Y; Li R; Qiao J
Clin Endocrinol (Oxf); 2018 Dec; 89(6):779-788. PubMed ID: 30106166
[TBL] [Abstract][Full Text] [Related]
10. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
11. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
12. Serum LBP Is Associated with Insulin Resistance in Women with PCOS.
Zhu Q; Zhou H; Zhang A; Gao R; Yang S; Zhao C; Wang Y; Hu J; Goswami R; Gong L; Li Q
PLoS One; 2016; 11(1):e0145337. PubMed ID: 26799617
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of interleukin-18 are associated with insulin resistance in women with polycystic ovary syndrome.
Zhang YF; Yang YS; Hong J; Gu WQ; Shen CF; Xu M; Du PF; Li XY; Ning G
Endocrine; 2006 Jun; 29(3):419-23. PubMed ID: 16943580
[TBL] [Abstract][Full Text] [Related]
14. Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome.
Fulghesu A; Magnini R; Portoghese E; Angioni S; Minerba L; Melis GB
J Adolesc Health; 2010 May; 46(5):474-81. PubMed ID: 20413084
[TBL] [Abstract][Full Text] [Related]
15. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
[TBL] [Abstract][Full Text] [Related]
16. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte expression of glucose transporter 1 and 4 in PCOS: Relationship to insulin-mediated and non-insulin-mediated whole-body glucose uptake.
Ezeh U; Chen IY; Chen YH; Azziz R
Clin Endocrinol (Oxf); 2019 Apr; 90(4):542-552. PubMed ID: 30623452
[TBL] [Abstract][Full Text] [Related]
18. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
19. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
Durmus U; Duran C; Ecirli S
J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
[TBL] [Abstract][Full Text] [Related]
20. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance.
O'Connor A; Phelan N; Tun TK; Boran G; Gibney J; Roche HM
J Clin Endocrinol Metab; 2010 Mar; 95(3):1378-85. PubMed ID: 20080859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]